Yuvisef 200 LB Tablet DT is a combination antibiotic formulation containing Cefixime 200 mg and Lactobacillus 60 million spores, designed for the treatment of bacterial infections while supporting gastrointestinal health. Cefixime, a third-generation cephalosporin antibiotic, exhibits broad-spectrum activity against various Gram-positive and Gram-negative bacteria by inhibiting bacterial cell wall synthesis, leading to cell death. It is effective in managing infections such as urinary tract infections, respiratory tract infections, otitis media, and uncomplicated gonorrhea. The inclusion of Lactobacillus, a probiotic containing beneficial live bacteria spores, helps restore and maintain the natural balance of gut flora, which may be disrupted during antibiotic therapy. This dual-action formulation not only targets pathogenic bacteria but also minimizes antibiotic-associated diarrhea and other gastrointestinal disturbances by promoting healthy intestinal microflora. Yuvisef 200 LB Tablet DT is administered orally and is suitable for patients requiring effective antimicrobial treatment with added probiotic support. It should be used under medical supervision, with dosage and duration tailored to the specific infection and patient condition. Caution is advised in patients with known hypersensitivity to cephalosporins or probiotics. This combination enhances therapeutic outcomes by combining antimicrobial efficacy with gut flora protection.